>
>
Anti-Obesity Drugs Market - By Product, Action Pathway, Distribution Channel – Global Forecast, 2024 – 2032
Download Free PDF

Anti-Obesity Drugs Market
Get a free sample of this reportGet a free sample of this report Anti-Obesity Drugs Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 15
Tables & Figures: 215
Countries covered: 23
Pages: 200
Download Free PDF
Anti-Obesity Drugs Market Size
The global anti-obesity drugs market size was valued at around USD 5.6 billion in 2023 and is estimated to grow at 27% CAGR from 2024 to 2032. Anti-obesity drugs are prescription medicines that modify physiological processes linked to hunger, metabolism, and nutrient absorption in order to help people lose weight and manage their obesity. These medications may increase metabolism, reduce appetite or inhibit the fat absorption, among others.
The increasing prevalence of obesity and related health issues are the key factors driving the growth of the market. For instance, a report from the World Health Organization (WHO) estimated that, in 2022, one in eight people suffered from obesity globally. Further, 2.5 billion adults aged 18 and above suffered from obesity, were as 890 million cases classified as obese. Additionally, 37 million children below the age of five were overweight. Thus, this highlights the growing need for effective solutions such as anti-obesity drugs, which help individuals to maintain their weight, improve their health, and tackle the global obesity problem.
Additionally, the obesity epidemic has become worse by various factors such as sedentary lifestyle, easy availability of high calories meals, thus necessitating the use of supplementary medical intervention.
Additionally, government regulations and guidelines play a vital role in shaping the anti-obesity drugs market, by ensuring safety and efficiency of medicine. For instance, initiatives such as the FDA Fast Track Designation for weight management medications are accelerating the need for new drug approvals. These regulations also assist in the research innovation, escalating the development of advanced treatments. Thus, technological innovations such as personalized medicine, AI-driven drug discovery, are fueling the creation for more effective and targeted anti-obesity drugs.
Anti-Obesity Drugs Market Trends
Anti-Obesity Drugs Market Analysis
Based on product, the market is bifurcated into prescription drugs and OTC drugs. The global market was estimated at USD 5.6 billion in 2023. The prescription drugs segment held revenue of USD 4.1 billion in 2023 and the segment is poised for significant growth at a CAGR of 27.1% during the forecast period.
Based on action pathway, the anti-obesity drugs market is bifurcated into peripherally acting drugs and centrally acting drugs. The centrally acting drugs segment accounted for a revenue share of 63.6% and with revenue of USD 3.5 billion in 2023.
Based on distribution channel, the anti-obesity drugs market is segmented into retail pharmacies, e-commerce, drug stores, and hospital pharmacies. The retail pharmacies segment held the largest revenue of USD 2.3 billion in 2023.
The North America anti-obesity drugs market is accounted for 2.5 billion revenues in 2023 forecasted to reach USD 21.9 billion by 2032. The U.S. dominated the North America market with the largest revenue of USD 2.3 billion in 2023.
Europe: Anticipate significant growth in UK’s anti-obesity drugs market from 2024 to 2032.
Asia pacific: Japan anti-obesity drugs market is poised for substantial growth between 2024 and 2032.
Middle East and Africa: Expect noteworthy growth in Saudi Arabia's anti-obesity drugs market from 2024 to 2032.
For instance, according to the data from National Institute of Health (NIH), in 2023, one fifth of the population was overweight or obese, which is 9.4%. The rising obesity cases was highest among children aged between 2 to 6 years is 12.3%, which was highest among boys, 10.4% than girls, 8.3%.
Anti-Obesity Drugs Market Share
The top 4 players of the anti-obesity market account for approximately 55% of the market share which includes companies such as Eli Lily & Co, Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals, Inc, among others. Moreover, strategic partnerships with pharmaceutical companies, research institutes, and government agencies play a primary role in advancing the development of medications and getting the necessary permits. The development of public awareness about obesity and its health impact through the social media platform, will encourage more individuals to seek the treatment, enabling market players to strengthen their position in this growing sector.
Anti-Obesity Drugs Market Companies
Some of the eminent market participants operating in the anti-obesity drugs industry include:
Anti-Obesity Drugs Industry News:
The anti-obesity drugs market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Action Pathway
Market, By Distribution Channel
The above information is provided for the following regions and countries: